1 |
Campos-López B, Meza-Meza MR, Pesqueda-Cendejas K, Ruiz-Ballesteros AI, Rivera-Escoto M, Vargas-Morales JM, Parra-Rojas I, Mora-García PE, Vizmanos B, Montoya-Buelna M, Cerpa-Cruz S, De la Cruz-Mosso U. Nutritional, biochemical, and clinical determinants of hyperuricemia in systemic lupus erythematosus patients: Relationship with clinical and renal disease activity. Lupus 2022;:9612033221146923. [PMID: 36562214 DOI: 10.1177/09612033221146923] [Reference Citation Analysis]
|
2 |
Richter P, Cardoneanu A, Rezus C, Burlui AM, Rezus E. Non-Traditional Pro-Inflammatory and Pro-Atherosclerotic Risk Factors Related to Systemic Lupus Erythematosus. IJMS 2022;23:12604. [DOI: 10.3390/ijms232012604] [Reference Citation Analysis]
|
3 |
Wang Y, Su W, Li Y, Yuan J, Yao M, Su X, Wang Y. Analyzing the pathogenesis of systemic lupus erythematosus complicated by atherosclerosis using transcriptome data. Front Immunol 2022;13:935545. [DOI: 10.3389/fimmu.2022.935545] [Reference Citation Analysis]
|
4 |
Liu Y, Yu X, Zhang W, Zhang X, Wang M, Ji F. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus. J Autoimmun 2022;:102863. [PMID: 35853760 DOI: 10.1016/j.jaut.2022.102863] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
5 |
Elshikha AS, Teng XY, Kanda N, Li W, Choi S, Abboud G, Terrell M, Fredenburg K, Morel L. TLR7 Activation Accelerates Cardiovascular Pathology in a Mouse Model of Lupus. Front Immunol 2022;13:914468. [DOI: 10.3389/fimmu.2022.914468] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
6 |
Grayson PC, Kaplan MJ. Diseases of blood vessels: Immune system involvement in vasculitis and vasculopathy. Semin Immunopathol 2022;44:255-8. [PMID: 35503576 DOI: 10.1007/s00281-022-00929-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|